Linezolid (Zyvox)


Indications

Community-Acquired Pneumonia (CAP)

Healthcare-Associated Pneumonia (HAP)

Uncomplicated and Complicated Skin/Skin Structure Infections

FDA-Approved for Treatment of Resistant Gram-Positive Bacterial Infections


Pharmacology

Metabolism


Administration

Dose Adjustment


Adverse Effects

Gastrointestinal Adverse Effects

Hematologic Adverse Effects

Neurologic Adverse Effects

Opthalmologic Adverse Effetcs

Renal Adverse Effects

Toxicologic Adverse Effects

Other Adverse Effects


References